PathCision Medicine
Watertown, US · Founded 2022 · Delaware corporation
Founders & leadership
HW
Hui-Hsuan WangNamed on SEC filing
YL
Yang LeeNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 2 rounds · 2022–2024
▶$1.7MraisedFeb 2026 · 8 investors · BiotechnologyRule 506(b)
▶$1.7MraisedFeb 2026 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hui-Hsuan WangExecutive Officer, Director
- Yang LeeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.7M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$600KraisedDec 2022 · 3 investors · BiotechnologyRule 506(b)
▶$600KraisedDec 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hui-Hsuan WangExecutive Officer, Director
- Yang LeeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $600K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has PathCision Medicine raised?
- PathCision Medicine has disclosed $2.3M raised across 2 rounds.
- Where is PathCision Medicine headquartered?
- PathCision Medicine is headquartered in Watertown, US.